Traitement du cancer de la prostate par pions à l'institut Paul Scherrer (autrefois Swiss Institute for Nuclear Research (SIN)) de 1983 à 1992;Traitement du cancer de la prostate par pions à l'institut Paul Scherrer (autrefois Swiss Institute for Nuclear Research (SIN)) de 1983 à 1992

Cancer/Radiotherapie

Volumn 8, Issue 2, 2004, Pages 88-94

  Wisser, L ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

Cancer de la prostate; Complications tardives s v res; Hadron therapy; Hadronth rapie; Late toxicity; Pion therapy; Pionth rapie; Prostate cancer; Radiation therapy; Radioth rapie

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MEDICAL ASSESSMENT; METASTASIS; PION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE; SWITZERLAND; CHILD; COMPARATIVE STUDY; FOLLOW UP; LYMPH NODE METASTASIS; MESON; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RADIATION DOSE; RADIOTHERAPY; SURVIVAL; TIME; TUMOR RECURRENCE;

AGED; CHILD; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MESONS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 2342512843     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2003.12.004     Document Type: Article

References (30)

1. Banker F.L. The preservation of potency after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 2615:1988;219-220.
2. Benk V.A., Adams J.A., Shipley W.U., Urie M.M., McManus P.L., Efird J.T., et al. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys. 26:1993;551-557.
3. Blattmann H. Pions at Los Alamos, PSI and Vancouver. Amaldi U., Larsson B. Hadrontherapy in Oncology. 1994;199-207 Elsevier, Amsterdam-Lausanne-New York-Oxford-Shannon-Tokyo.
4. Fowler P.H., Perkins D.H. The possibility of therapeutic application of beams of negative pi-mesons. Nature. 189:1961;524-528.
5. Hanks G.E., Hanlon A.L., Schultheiss T.E., Pinover W.E., Movsas B., Epstein B.E., et al. Dose escalation with 3-D conformal treatment: five year outcomes, treatment optimisation, and future directions. Int J Radiat Oncol Biol Phys. 41:(3):1998;501-510.
6. Hanks G.E., Lee W.L., Hanlon A.L., Hunt M., Kaplan E., Epstein B.E., et al. Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >10 ng/ml. Int J Radiat Oncol Biol Phys. 35:(5):1996;861-868.
7. Hanks G.E., Schultheiss T.E., Hanlon A.L., Hunt M., Lee W.R., Epstein B.E., et al. Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study. Int J Radiat Oncol Biol Phys. 37:(3):1997;543-550.
8. Hanks G.E. Optimizing the radiation treatment and outcome of prostate cancer. Int J Radiat Oncol Biol Phys. 11:1985;1235-1245.
9. Helgason A., Fredrikson M., Adolfson J., Steineck G. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol Phys. 32:(1):1995;33-39.
10. Kuban D.A., El-Mahdi A.M., Schellhammer P.F. PSA for outcome prediction and posttreatment evaluation following radiation for prostate cancer: do we know how to use it? Tepper J.E. Seminars in radiation oncology. 8(2):1998;72-80.
11. Lawton C.A., Won M., Pilepich M.V., Asbell S.O., Shipley W.U., Hanks G.E., et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 21:1991;935-939.
12. Noel G., Feuvret L., Ferrand R., Mazeron J.-J. Treatment with charged particle beams: hadrontherapy part I: physical basis and clinical experience of treatment with protons. Cancer radiother. 6:(6):2002;369-378.
13. Noel G., Feuvret L., Ferrand R., Mazeron J.-J. Treatment with neutrons: hadrontherapy part II: physical basis and clinical experience. Cancer Radiother. 7:(5):2003;340-352.
14. Perez C.A., Hanks G.E., Leibel S.A., Zietman A.L., Fuks Z., Lee W.R. Localized carcinoma of the prostate (Stages T1b, T1c, T2 and T3). Cancer. 72:(11):1993;3156-3173.
15. Pickles T., Bowen J., Dixon P., et al. Pions - the potential for therapeutic gain in locally advanced prostate cancer: dose escalation and toxicity studies. Int J Radiat Oncol Biol Phys. 21:1991;1005-1011.
16. Pickles T., Goodman G.B., Fryer C.J., Bowen J., Coldman A.J., Duncan G.G., et al. Pion conformal radiation of prostate cancer: results of a randomized study. Int J Radiat Oncol Biol Phys. 43:(1):1999;47.
17. Pollack A., Zagars G.K., Starkschall G., Childress C.H., Kopplin S., Boyer A.L., et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys. 34:(3):1996;555-564.
18. Pollack A., Zagars G.K. Androgen ablation in addition to radiation therapy for prostate cancer: is there a true benefit? Tepper J.E. Seminars in radiation oncology. 8(2):1998;95-106.
19. Pollack A., Zagars G.K. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 39:(5):1997;1011-1018.
20. Pommier P., Balosso J., Bolla M., Gerard J.P. The French project ETOILE: review of clinical data for light ion hadrontherapy. Cancer radiother. 7:(5):2002;368-378.
21. Roach M., Chinn D.M., Holland J., Clarke M. A pilot study of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 35:(5):1996;869-874.
22. Rossi C.J., Slater J.D., Reyes-Molyneux N., Yonemoto L.T., Archambeau J.O., Coutrakan G., et al. Particle beam radiation therapy in prostate cancer: is there an advantage? Tepper J.E. Seminars in radiation oncology. 8(2):1998;81-86.
23. Schild S.E. Radiation therapy after prostatectomy: now or later? Tepper J.E. Seminars in radiation oncology. 8(2):1998;132-139.
24. Studer U., Gerber E., Zimmermann A., Kraft R., von Essen C.F. Late results in patients treated with pi-mesons for bladder cancer. Cancer. 71:(2):1993;439-447.
25. Takai M., Blattmann H., Pedroni E. An intercomparison of two dynamic treatment techniques, ring scan and spot scan, for head and neck tumors with the piotron. Int J Radiat Oncol Biol Phys. 14:1988;1025-1031.
26. von Essen C.F., Bagshaw M.A., Bush S.E., Smith A.R., Kligerman M.M. Long-term results of pion therapy at Los Alamos. Int J Radiat Oncol Biol Phys. 13:1987;1389-1398.
27. Zelefsky M.J., Leibel S.A., Gaudin P.B., Kutcher G., Fleshner N.E., Venkatramen E.S., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:(3):1998;491-500.
28. Zelefsky M.J., Leibel S.A., Kutcher G.J., Fuks Z. Three-dimensional conformal radiotherapy and dose escalation: where do we stand. Tepper J.E. Seminars in radiation oncology. 8(2):1998;107-114.
29. Zietman A.L. Radiation therapy or prostatectomy: an old conflict revisited in the PSA era. A radiation oncologist's viewpoint. Tepper J.E. Seminars in radiation oncology. 8(2):1998;81-86.
30. Zinreich E.S., Derogatis L.R., Herpst J., Auvil G., Piantadosi S., Order S.E. Pre and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 19:1990;729-732.